RxDoctor Payments Data

Rachel Duke

Acute Care · Richmond, VANPI 1063716033

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $581,073 of the $750,606 with a category attached, or 77.4%. AbbVie accounts for 99.6% of it on its own, with 4 other manufacturers making up the rest. Among acute care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$750,606in general payments, 2019–2025

Across 819 payments — averaging $916.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$747K
  • Musculoskeletal Transplant Foundation Inc.$3K
  • Galderma Laboratories, L.p.$602
  • Revance Therapeutics, Inc.$87
  • Biogen$42

What the payments were for

  • Consulting fees$60,5438%
  • Speaking & faculty fees$581,07377%
  • Travel & lodging$91,88512%
  • Food & beverage$17,0972%
  • Education$80%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$750,606 in reported general payments places this provider in the 95th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Other acute care in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →